A Phase II Study of sEphB4-HSA in Kaposi Sarcoma

Trial Profile

A Phase II Study of sEphB4-HSA in Kaposi Sarcoma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Oct 2017

At a glance

  • Drugs SEphB4-HSA (Primary)
  • Indications Kaposi's sarcoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 14 Sep 2016 Status changed from suspended to recruiting. The study was suspended due to drug supply issues.
    • 20 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top